Amprius Q2: The Growth Thesis Is Stronger But H2 Will Be The Real Test

Amprius Technologies reported Q2 revenue up 126% to $34M and expanded gross margin to 27%, alongside an improved 2026 outlook. The company also cited new commercial traction, including a $24M drone order and a multi-year Stark Future deal, which supports positioning but highlights execution risk. While valuation has improved to ~11x 2026 revenue, an upgrade from Hold still hinges on progress on profitability and cash conversion.

Analysis

The main investable takeaway is not the top-line growth; it is whether AMPX is crossing from “interesting materials story” into a repeatable industrial supplier with enough mix leverage to self-fund growth. If the gross-margin step-up is driven by higher-volume programs rather than one-off pricing, the business can re-rate quickly because every incremental point of margin matters disproportionately for a pre-profit hardware name. The flip side is that a single large drone order can make the quarter look cleaner than the underlying demand curve actually is, so investors should treat the current signal as proof of product-market fit, not proof of durable scale.

Competitive dynamics favor AMPX only if it can keep winning missions where energy density matters more than cost per kWh. That creates second-order pressure on legacy battery suppliers in aerospace/defense-adjacent applications, and it should support end customers like AVAV and KTOS if longer endurance lowers platform operating costs. But the real bottleneck is manufacturing quality and working capital: if receivables/inventory absorb cash faster than gross profit improves, the market will keep discounting dilution risk even if revenue growth stays strong.

The contrarian view is that the stock may already be getting credit for a cleaner 2026 path than is warranted. At 11x 2026 revenue, the market is implicitly paying for continued execution; any slip in backlog conversion, margin backsliding below the mid-20s, or a pause in new orders would compress the multiple fast. Near term, the next 1-2 quarters are about proof of repeatability; over 6-18 months, the thesis depends on whether AMPX can turn design wins into cash generation instead of just headline growth.

Key Decisions for Investors

• Keep AMPX as a small starter long only on confirmation that the next quarter shows sequential revenue growth and gross margin holds above 25%; target a 20-30% rerating if the market starts underwriting a credible 2026 free-cash-flow path, but cut if growth drops below ~60% YoY or gross margin falls back under 20%.
• Relative-value trade: long AMPX / short QS in equal dollars for 1-3 months. The thesis is that AMPX has nearer-term commercial proof, while QS remains more dependent on future-scale narratives; cover the short if QS secures funded production milestones or if AMPX order conversion disappoints.
• For higher-conviction entry, wait for a post-earnings pullback and use a 3-6 month AMPX call spread rather than common stock. The risk/reward works only if investors re-anchor on margin durability, not just revenue growth; abandon if guidance implies working-capital outflow persists.
• Watch AVAV and KTOS as downstream beneficiaries of better battery performance in drone platforms. If AMPX’s customers keep scaling, these names can gain from longer range/endurance and lower operating friction, even if AMPX itself remains too execution-sensitive for a large position.
• No aggressive long should be put on until cash conversion improves; if operating cash burn worsens despite margin gains, treat that as a falsifier and expect the multiple to compress back toward sub-10x 2026 revenue.